Published in Oncotarget on November 15, 2016
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol (2010) 16.24
Practical methods for incorporating summary time-to-event data into meta-analysis. Trials (2007) 14.51
TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition. Oncogene (2007) 1.58
Novel insights into proteolytic cleavage of influenza virus hemagglutinin. Rev Med Virol (2010) 1.34
TMPRSS4 induces invasion and epithelial-mesenchymal transition through upregulation of integrin alpha5 and its signaling pathways. Carcinogenesis (2010) 1.30
ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy. Ann Surg (2005) 1.27
Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology. Br J Cancer (2011) 1.09
Prognostic value of TMPRSS4 expression in patients with breast cancer. Med Oncol (2013) 1.01
TMPRSS4-dependent activation of the epithelial sodium channel requires cleavage of the γ-subunit distal to the furin cleavage site. Am J Physiol Renal Physiol (2011) 1.00
TMPRSS4 regulates levels of integrin α5 in NSCLC through miR-205 activity to promote metastasis. Br J Cancer (2014) 1.00
TMPRSS4 as a poor prognostic factor for triple-negative breast cancer. Int J Mol Sci (2013) 0.92
TMPRSS4 upregulates uPA gene expression through JNK signaling activation to induce cancer cell invasion. Cell Signal (2013) 0.92
TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection. Sci Rep (2015) 0.88
TMPRSS4: an emerging potential therapeutic target in cancer. Br J Cancer (2014) 0.86
Expression of TMPRSS4 in patients with salivary adenoid cystic carcinoma: correlation with clinicopathological features and prognosis. Med Oncol (2013) 0.86
Membrane Proteins Involved in Epithelial-Mesenchymal Transition and Tumor Invasion: Studies on TMPRSS4 and TM4SF5. Genomics Inform (2014) 0.85
Morpholino knockdown of the ubiquitously expressed transmembrane serine protease TMPRSS4a in zebrafish embryos exhibits severe defects in organogenesis and cell adhesion. Biol Chem (2011) 0.85
Prognostic significance of TMPRSS4 in gastric cancer. Neoplasma (2014) 0.85
TMPRSS4 induces cancer cell invasion through pro-uPA processing. Biochem Biophys Res Commun (2014) 0.84
Clinical implication of TMPRSS4 expression in human gallbladder cancer. Tumour Biol (2014) 0.84
Role of TMPRSS4 during cancer progression. Drug News Perspect (2008) 0.84
High expression level of TMPRSS4 predicts adverse outcomes of colorectal cancer patients. Med Oncol (2013) 0.84
TMPRSS4 correlates with colorectal cancer pathological stage and regulates cell proliferation and self-renewal ability. Cancer Biol Ther (2013) 0.84
High TMPRSS4 expression is a predictor of poor prognosis in cervical squamous cell carcinoma. Cancer Epidemiol (2013) 0.84
Transmembrane protease serine 4 promotes thyroid cancer proliferation via CREB phosphorylation. Thyroid (2015) 0.84
The expression of TMPRSS4 and Erk1 correlates with metastasis and poor prognosis in Chinese patients with gastric cancer. PLoS One (2013) 0.83
Methylation-induced downregulation of TFPI-2 causes TMPRSS4 overexpression and contributes to oncogenesis in a subset of non-small-cell lung carcinoma. Cancer Sci (2014) 0.83
Vitamin D receptor expression is linked to potential markers of human thyroid papillary carcinoma. J Steroid Biochem Mol Biol (2016) 0.82
TMPRSS4 induces cancer stem cell-like properties in lung cancer cells and correlates with ALDH expression in NSCLC patients. Cancer Lett (2015) 0.81
Epigenetic alterations leading to TMPRSS4 promoter hypomethylation and protein overexpression predict poor prognosis in squamous lung cancer patients. Oncotarget (2016) 0.79
TMPRSS4 Expression as a Marker of Recurrence in Patients with Lung Cancer. Anticancer Res (2016) 0.77
Clinical significance of TMPRSS4 in prostate cancer. Int J Clin Exp Pathol (2014) 0.77